Subtype
Intracranial Neoplasm
CI-CAN-00001030Explore in graph →
Non-malignant521 active trials34 evidence items
- NCIt
- C4953
Loading cancer entity…
Subtype
CI-CAN-00001030Explore in graph →
Clinical trials
2,177 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02523014 | Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas | recruiting | Phase 2 | 124 | Alliance for Clinical Trials in OncologyOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT06860594 | Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma | recruiting | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Sep 2, 2026 | clinicaltrials |
| NCT07799623 | Ciprofol, Propofol and Sevoflurane for Postoperative Delirium in Elderly Brain Tumor Patients | not yet recruiting | N/A | 381 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT01875601 | NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors | completed | Phase 1 | 16 | National Cancer Institute (NCI)NIH | 1 | Sep 1, 2026 | clinicaltrials |
| NCT03678389 | Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery | recruiting | N/A | 70 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Sep 1, 2026 | clinicaltrials |
| NCT05538130 | A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors | active not recruiting | Phase 1 | 148 | PfizerINDUSTRY | 7 | Sep 1, 2026 | clinicaltrials |
| NCT06161974 | Study of Olutasidenib and Temozolomide in HGG | recruiting | Phase 2 | 60 | Rigel PharmaceuticalsINDUSTRY | 7 | Sep 1, 2026 | clinicaltrials |
| NCT07180927 | DLL3 CAR-T Therapy Targeting Brain Tumors | not yet recruiting | Phase 1 / Phase 2 | 30 | Shenzhen Geno-Immune Medical InstituteOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT07242963 | Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study | recruiting | — | 300 | Mohammad H. Abu ArjaOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT07797660 | A Study for Postoperative Delirium in Older Patients With Intracranial Tumors | not yet recruiting | — | 164 | Beijing Tiantan HospitalOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT02594709 | Multisession Radiosurgery for Optic Nerve Sheath Meningiomas(ONSMsmSRS) | completed | N/A | 56 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT02974127 | Multisession Radiosurgery in Large Meningiomas(MuRaLM) | completed | — | 178 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT06506578 | Nausea Induced by Radiation of the Dorsal Vagal Complex for Benign Brain Tumors (NausiCAA)(NausiCAA) | completed | — | 100 | University Hospital, BordeauxOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT07796061 | Blood-Brain Barrier Disruption Using Exablate Magnetic Resonance-Guided Low Intensity Focused Ultrasound With Microbubbles in Combination With T-Cell Infusion in Patients With Newly Diagnosed Diffuse Midline Glioma (LIFT)(LIFT) | not yet recruiting | Phase 1 | 45 | Children's National Research InstituteOTHER | 0 | Aug 31, 2026 | clinicaltrials |
| NCT01503086 | Computer Training Program for Younger Patients With a Brain Tumor Who Underwent Radiation Therapy | completed | N/A | 45 | Children's Oncology GroupNETWORK | 2 | Aug 28, 2026 | clinicaltrials |
| NCT02639325 | Tumor Related Epilepsy | recruiting | — | 100 | National Institute of Neurological Disorders and Stroke (NINDS)NIH | 1 | Aug 28, 2026 | clinicaltrials |
| NCT02851706 | Natural History of and Specimen Banking for People With Tumors of the Central Nervous System | completed | — | 1,214 | National Cancer Institute (NCI)NIH | 1 | Aug 28, 2026 | clinicaltrials |
| NCT04181684 | LITT Followed by Hypofractionated RT for Recurrent Gliomas(GCCC 19140) | active not recruiting | N/A | 39 | University of Maryland, BaltimoreOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT05588141 | A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations | recruiting | Phase 1 / Phase 2 | 96 | National Cancer Institute (NCI)NIH | 1 | Aug 28, 2026 | clinicaltrials |
| NCT07278440 | An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregivers, ET-NEURO Trial | recruiting | N/A | 36 | OHSU Knight Cancer InstituteOTHER | 1 | Aug 28, 2026 | clinicaltrials |
| NCT03975829 | Pediatric Long-Term Follow-up and Rollover Study | active not recruiting | Phase 4 | 163 | Novartis PharmaceuticalsINDUSTRY | 19 | Aug 27, 2026 | clinicaltrials |
| NCT06474533 | Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm | recruiting | — | 199 | Thomas HopeOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT07501156 | H3K27M-specific Immune Effector Cells Targeting DMG/DIPG | not yet recruiting | Phase 1 / Phase 2 | 30 | Shenzhen Geno-Immune Medical InstituteOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT07789938 | Intraoperative Neurophysiological Monitoring in Brain Tumor Surgery: Prospective Cohort Studies | not yet recruiting | N/A | 166 | Odense University HospitalOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT05857969 | Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling | recruiting | Phase 1 | 65 | Florida International UniversityOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT06701812 | Digoxin Medulloblastoma Study | recruiting | Phase 2 | 23 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT02956291 | Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors | completed | N/A | 170 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 25, 2026 | clinicaltrials |
| NCT05382338 | A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss | recruiting | Phase 3 | 225 | Children's Oncology GroupNETWORK | 2 | Aug 25, 2026 | clinicaltrials |
| NCT05948813 | TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases | recruiting | Phase 2 | 420 | TYK Medicines, IncINDUSTRY | 1 | Aug 25, 2026 | clinicaltrials |
| NCT06368817 | A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma | recruiting | Phase 2 | 240 | Children's Oncology GroupNETWORK | 3 | Aug 25, 2026 | clinicaltrials |
| NCT07437820 | Study Comparing Neoadjuvant Versus Adjuvant Stereotactic Radiotherapy of Brain Metastases(NeoSRS) | not yet recruiting | N/A | 68 | GCS Ramsay Santé pour l'Enseignement et la RechercheOTHER | 1 | Aug 25, 2026 | clinicaltrials |
| NCT07786311 | University of Kentucky Markey Cancer Center Neuro-Oncology Multi-Disciplinary Tumor Board Protocol for the Treatment of Advanced Brain Metastases | not yet recruiting | N/A | 125 | John L. Villano, MD, PhDOTHER | 0 | Aug 25, 2026 | clinicaltrials |
| NCT02693990 | A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas | active not recruiting | N/A | 21 | Massachusetts General HospitalOTHER | 1 | Aug 24, 2026 | clinicaltrials |
| NCT03170141 | Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme | terminated | Phase 1 | 30 | Shenzhen Geno-Immune Medical InstituteOTHER | 1 | Aug 24, 2026 | clinicaltrials |
| NCT03286335 | Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy | recruiting | N/A | 100 | Massachusetts General HospitalOTHER | 1 | Aug 24, 2026 | clinicaltrials |
| NCT05096481 | PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma | recruiting | Phase 2 | 120 | Nationwide Children's HospitalOTHER | 1 | Aug 24, 2026 | clinicaltrials |
| NCT00268385 | Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas | active not recruiting | Phase 1 | 83 | National Cancer Institute (NCI)NIH | 1 | Aug 20, 2026 | clinicaltrials |
| NCT00918320 | Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours(TOTEM2) | completed | Phase 2 | 129 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT01419067 | A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection | active not recruiting | Phase 2 | 112 | St. Jude Children's Research HospitalOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT03750227 | Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors | recruiting | Phase 3 | 140 | Mayo ClinicOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT05317858 | Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets(LIMITLESS) | recruiting | Phase 3 | 30 | InSightecINDUSTRY | 3 | Aug 19, 2026 | clinicaltrials |
| NCT07091396 | Home Transcranial Direct Current Stimulation (tDCS) to Enhance Functional Recovery | active not recruiting | N/A | 55 | Mayo ClinicOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT07660458 | Parental Distress and Treatment Adherence in Pediatric Recurrent Medulloblastoma | withdrawn | — | 0 | West China HospitalOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT07772323 | Bedside Cranial Ultrasound for Risk-Stratified Imaging in Pediatric Acute Brain Injury(CUPID-Peds) | not yet recruiting | — | 220 | Virginia Commonwealth UniversityOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT03122197 | Study of Letrozole in Recurrent Gliomas | recruiting | Early Phase 1 | 39 | University of CincinnatiOTHER | 1 | Aug 18, 2026 | clinicaltrials |
| NCT03173950 | Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers | terminated | Phase 2 | 136 | National Cancer Institute (NCI)NIH | 1 | Aug 18, 2026 | clinicaltrials |
| NCT04047264 | Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions | recruiting | N/A | 100 | Mayo ClinicOTHER | 1 | Aug 18, 2026 | clinicaltrials |
| NCT07226466 | Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer | not yet recruiting | — | 40 | University of California, San FranciscoOTHER | 1 | Aug 18, 2026 | clinicaltrials |
| NCT07767110 | Targeted LSAM-Cisplatin Infusion in Gliomas, Evaluation of Response(TIGER-1) | not yet recruiting | Phase 1 / Phase 2 | 20 | NanOlogy, LLCINDUSTRY | 0 | Aug 18, 2026 | clinicaltrials |
| NCT00407433 | Clinical Studies of Gemcitabine-Oxaliplatin | completed | Phase 2 | 156 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Aug 17, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Sep 2, 2026source: clinicaltrials